Literature DB >> 8109803

Immune mechanisms in chronic inflammatory bowel disease.

C P Braegger1, T T MacDonald.   

Abstract

Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases of unknown etiology. However, there is circumstantial evidence that immune mechanisms play an important role in the pathogenesis of the intestinal lesion, and cytokines produced by lymphoid cells may be critical for the extraintestinal sequelae of the disease. In both Crohn's disease and ulcerative colitis, activation of macrophages seems to be a key feature. Increased production of the macrophage derived cytokines TNF-alpha, IL-1 and IL-6 have been reported in both diseases. Additionally in Crohn's disease, large numbers of activated T lymphocytes can be detected in the lamina propria and the T lymphocyte derived cytokines IL-2 and IFN-gamma are secreted by a higher number of lamina propria T lymphocytes in active Crohn's disease. However, this is not the case in ulcerative colitis. The increased number of activated T lymphocytes secreting IFN-gamma may be responsible for granuloma formation in Crohn's disease, as well as for MHC class II antigen expression on colonic epithelial cells. Lamina propria T lymphocytes seem to have lost their physiological unresponsiveness to several microbial antigens. All these observations suggest that Crohn's disease may be caused by hyperreaction of the local cellular immune system to numerous microbial and nutritional antigens normally present in the intestine. The factor inducing this immune dysregulation remains unknown. Cell-mediated immunity seems to be less important in ulcerative colitis, as activated T lymphocytes are only sparse within the inflamed mucosa, and the T lymphocyte derived cytokines IL-2 and IFN-gamma cannot be detected in the gut lesion or in the serum.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8109803

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  30 in total

Review 1.  Sphingolipids in inflammation: pathological implications and potential therapeutic targets.

Authors:  Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

Review 2.  Cytokine regulation of epithelial permeability and ion transport.

Authors:  D M McKay; A W Baird
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 3.  The gut as a lymphoepithelial organ: the role of intestinal epithelial cells in mucosal immunity.

Authors:  H Tlaskalová-Hogenová; M A Farré-Castany; R Stĕpánková; H Kozáková; L Tucková; D P Funda; R Barot; B Cukrowska; J Sinkora; L Mandel
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

4.  Growth factor mRNA expression in normal colorectal mucosa and in uninvolved mucosa from ulcerative colitis patients.

Authors:  A Chowdhury; R Fukuda; S Fukumoto
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

5.  miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses.

Authors:  Udai P Singh; Angela E Murphy; Reilly T Enos; Haidar A Shamran; Narendra P Singh; Honbing Guan; Venkatesh L Hegde; Daping Fan; Robert L Price; Dennis D Taub; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

6.  Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation.

Authors:  Haidar Shamran; Narendra P Singh; Elizabeth E Zumbrun; Angela Murphy; Dennis D Taub; Manoj K Mishra; Robert L Price; Saurabh Chatterjee; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh
Journal:  Brain Behav Immun       Date:  2016-06-17       Impact factor: 7.217

7.  Changes in murine jejunal morphology evoked by the bacterial superantigen Staphylococcus aureus enterotoxin B are mediated by CD4+ T cells.

Authors:  M A Benjamin; J Lu; G Donnelly; P Dureja; D M McKay
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

8.  Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells.

Authors:  M W Leach; A G Bean; S Mauze; R L Coffman; F Powrie
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

9.  Local and systemic liberation of proinflammatory cytokines in ulcerative colitis.

Authors:  M Gotteland; M Lopez; C Muñoz; R Saez; H Altshiller; P Llorens; O Brunser
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

10.  Subclinical intestinal inflammation in patients with Crohn's disease following bowel resection: a smoldering fire.

Authors:  Cesare Ruffolo; Marco Scarpa; Diego Faggian; Daniela Basso; Renata D'Incà; Mario Plebani; Giacomo C Sturniolo; Nicolò Bassi; Imerio Angriman
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.